Cost Comparison of Licensed Intravitreal Therapies For Diabetic Macular Edema That Responds Insufficiently To Intravitreal Anti-Vegf – A German 3 Year Cost Model
Abstract
Authors
AS Neubauer J Subert C Haritoglou MW Ulbig